Xeris Pharmaceuticals is based in Chicago. It has raised $200M in total funding. Latest round: IPO.
Xeris Pharmaceuticals is based in Chicago. Xeris Pharmaceuticals has raised $200M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is an IPO announced in May 2017. The round record for Xeris Pharmaceuticals runs through 2017; nothing later has been disclosed. Investors on record include Redmile Group, Deerfield Management Company, Palmetto Partners, Wild Basin Investments, Asahi-Kasei Corporation, Bay City Capital and 1 others. 7 distinct backers are named across the disclosed rounds.
Round data for Xeris Pharmaceuticals is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Chicago and backer lists below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026